mTORC1 and DNA-PKcs as Novel Molecular Determinants of Sensitivity to Chk1 Inhibition

Molecular Oncology - Netherlands
doi 10.1016/j.molonc.2015.08.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

mTORC1/2 and Protein Translation Regulate Levels of CHK1 and the Sensitivity to CHK1 Inhibitors in Ewing Sarcoma Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Targeting Dna Double Strand Break Repair With Hyperthermia and Dna-PKCS Inhibition to Enhance the Effect of Radiation Treatment

Oncotarget
Oncology
2016English

DNA-PKcs Inhibition Sensitizes Cancer Cells to Carbon-Ion Irradiation via Telomere Capping Disruption

PLoS ONE
Multidisciplinary
2013English

Molecular Determinants of Site-Specific Inhibition of Human DNA Topoisomerase I by Fagaronine and Ethoxidine

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

DNA-PKcs, Allostery, and DNA Double-Strand Break Repair

DNA Repair Enzymes: Structure, Biophysics, and Mechanism
2017English

Tumour Growth Environment Modulates Chk1 Signalling Pathways and Chk1 Inhibitor Sensitivity

Scientific Reports
Multidisciplinary
2016English

Severe Combined Immunodeficiency Due to DNA-PKcs Deficiency

2020English

mTORC1 Inhibition Is Required for Sensitivity to PI3K P110 Inhibitors in PIK3CA-Mutant Breast Cancer

Science Translational Medicine
Medicine
2013English

Inhibition of Snail1-Dna-PKcs Protein-Protein Interface Sensitizes Cancer Cells and Inhibits Tumor Metastasis

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy